LEQEMBI ® [ (lecanemab-irmb) 100 mg/mL injection for intravenous use] is indicated for the treatment of Alzheimer's disease (AD). Treatment with LEQEMBI should be initiated in patients with mild ...
clear, timely and relevant communication is more than a regulatory ideal — it is integral to quality care and consumer trust in assisted living.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback